Risperidone, an antipsychotic medication, may have a pharmacodynamic interaction with the gene GRID2, which is involved in neurodevelopment and synaptic plasticity through its role in glutamate signaling pathways. This interaction mainly affects synaptic function and plasticity rather than influencing drug metabolism or transport.